Últimas noticias sobre United Breweries Co (NYSE:CCU) Bolsa

United Breweries Co

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Compania Cervecerias Unidas, S.A. Common Stock

United Breweries Co Inc

CCUR Holdings Inc

Goldman Sachs analyst Thiago Bortoluci maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Sell and lowers the price target from $10.5 to $9.4.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Sell on United Breweries Co, Lowers Price Target to $9.4

Earnings

Compania Cervecerias Unidas Q3 2024 EPS CLP80.0 Vs CLP25.7 YoY

United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-11-06. Here's what investors need to know before the announcement.
Analysts estimate that United Breweries Co will report an earnings per share (EPS) of $0.12. 
Investors in United Breweries Co are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.02, leading to a 2.81% increase in the share price on the subsequent day.
Here's a look at United Breweries Co's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.09</td>
<td>0.27</td>
<td>0.06</td>
<td>0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.07</td>
<td>0.75</td>
<td>0.25</td>
<td>0.25</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730836935_0.png" alt="eps graph" />
<h3>United Breweries Co Share Price Analysis</h3>
Shares of United Breweries Co were trading at $11.23 as of November 04. Over the last 52-week period, shares are down 8.51%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Insights on United Breweries Co</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on United Breweries Co.
United Breweries Co has received a total of 2 ratings from analysts, with the consensus rating as Sell. With an average one-year price target of $10.25, the consensus suggests a potential 8.73% downside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Boston Beer Co and Molson Coors Beverage, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>The consensus among analysts is an Neutral trajectory for Boston Beer Co, with an average 1-year price target of $340.5, indicating a potential 2932.06% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Molson Coors Beverage, with an average 1-year price target of $56.44, suggesting a potential 402.58% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Boston Beer Co and Molson Coors Beverage, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>United Breweries Co</td>
<td>Sell</td>
<td>-8.64%</td>
<td>$210.11B</td>
<td>0.35%</td>
</tr>
<tr>
<td>Boston Beer Co</td>
<td>Neutral</td>
<td>0.64%</td>
<td>$280.24M</td>
<td>3.26%</td>
</tr>
<tr>
<td>Molson Coors Beverage</td>
<td>Neutral</td>
<td>-0.44%</td>
<td>$1.33B</td>
<td>3.25%</td>
</tr>
</tbody>
</table>

Key Takeaway:
United Breweries Co ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is in the middle for Return on Equity.
<h3>Get to Know United Breweries Co Better</h3>
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
<h3>United Breweries Co: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: United Breweries Co's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -8.64%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 0.96%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): United Breweries Co's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.35%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): United Breweries Co's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.14%, the company may face hurdles in achieving optimal financial performance.
Debt Management: United Breweries Co's debt-to-equity ratio surpasses industry norms, standing at 0.99. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<a href="https://www.benzinga.com/quote/CCU/earnings">To track all earnings releases for United Breweries Co visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look at United Breweries Co's Upcoming Earnings Report

Goldman Sachs analyst Thiago Bortoluci downgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Neutral to Sell and lowers the price target from $12.9 to $10.5.

Downgrades

Goldman Sachs Downgrades United Breweries Co to Sell, Lowers Price Target to $10.5

JP Morgan analyst Lucas Ferreira downgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Overweight to Underweight and lowers the price target from $21 to $10.

JP Morgan Downgrades United Breweries Co to Underweight, Lowers Price Target to $10

ACAD

ACHC

AESI

AHCO

AIRS

ALEC

ALHC

AMBA

AMBC

APLS

ARKO

ARQT

ARRY

ATEC

AXON

BCSF

BECN

BGFV

BMBL

BWXT

BYND

CAVA

CBRL

CIVI

CLDT

CLNE

CLVT

CMLS

COMP

CPNG

CRDO

CYTK

EBAY

EHTH

ESPR

FARO

FLYW

FOUR

FSLR

FULC

GDOT

GLPI

GMRE

GSX Techedu Inc. American Depositary Shares

GOTU

GPOR

HRZN

HSIC

HURN

ICCC

ICFI

ICUI

IMAX

IMXI

INGN

INSE

IPAR

JAMF

KIND

KURA

KVYO

LAZR

LGND

LGVN

Earnings Scheduled For February 27, 2024

Jefferies analyst Alex Wright initiates coverage on United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Buy rating and announces Price Target of $15.22.

Initiation

Jefferies Initiates Coverage On United Breweries Co with Buy Rating, Announces Price Target of $15.22

Goldman Sachs maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Neutral and lowers the price target from $14.8 to $12.9.

Goldman Sachs Maintains Neutral on United Breweries Co, Lowers Price Target to $12.9

B of A Securities analyst Fernando Olvera downgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Buy to Neutral.

B of A Securities Downgrades United Breweries Co to Neutral

HSBC analyst Sorabh Daga upgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Hold to Buy and lowers the price target from $18 to $15.

Upgrades

HSBC Upgrades United Breweries Co to Buy, Lowers Price Target to $15

Goldman Sachs maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Neutral and lowers the price target from $16.8 to $14.8.

Goldman Sachs Maintains Neutral on United Breweries Co, Lowers Price Target to $14.8

HSBC analyst Sorabh Daga maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Hold and raises the price target from $16 to $18.

HSBC Maintains Hold on United Breweries Co, Raises Price Target to $18

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Tuesday.
The Dow traded down 0.92% to 33,562.53 while the NASDAQ fell 1.75% to 11,826.47. The S&amp;P 500, also fell, dropping, 1.40% to 4,079.31.
&nbsp;
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/23/04/31989198/bitcoin-ethereum-record-losses-pancakeswap-becomes-top-loser"> Bitcoin, Ethereum Record Losses; PancakeSwap Becomes Top Loser</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
<ul>
<li>Consumer staples shares rose by 0.1% on Tuesday. Meanwhile, top gainers in the <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a> included Compa&ntilde;&iacute;a Cervecer&iacute;as Unidas S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccu#NYSE">CCU</a>), up 4%, and Utz Brands, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/utz#NYSE">UTZ</a>), up 3%.</li>
<li>In trading on Tuesday, energy shares dipped by 2.1%.</li>
</ul>
&nbsp;
<h3>Top Headline</h3>
McDonald&#39;s Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcd#NYSE">MCD</a>) reported better-than-expected results for its first quarter.
McDonald&#39;s reported first-quarter FY23 sales growth of 4% year-on-year to $5.89 billion, beating the consensus of $5.59 billion. Adjusted EPS of $2.63 beat the analyst consensus of $2.33.
&nbsp;
<h3>Equities Trading UP</h3>
<ul>
<li>Virios Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viri#NASDAQ">VIRI</a>) shares shot up 32% to $2.0992 after the company announced initial FDA feedback on its proposed IMC-1 Phase 3 program for the treatment of fibromyalgia. The company said the proposed program is considered acceptable based on initial FDA feedback pending review of the final chronic toxicology program results.</li>
<li>Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sppi#NASDAQ">SPPI</a>) got a boost, shooting 24% to $0.8533 after Assertio announced it will acquire the company in an all-stock and CVR transaction.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) shares were also up, gaining 24% to $0.2630 after the company announced that it will not consummate the warrant inducement transaction that Agrify had previously announced on April 19, 2023.</li>
</ul>
&nbsp;
<h3>Equities Trading DOWN</h3>
<ul>
<li>First Republic Bank (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frc#NYSE">FRC</a>) shares dropped 40% to $9.62 after the company announced a decline in deposits for the first quarter and said it will reduce its workforce by 20-25%.</li>
<li>Shares of HomeStreet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hmst#NASDAQ">HMST</a>) were down 37% to $11.00 following weak Q1 earnings.</li>
<li>Vyant Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vynt#NASDAQ">VYNT</a>) was down, falling 41% to $0.3234 as the company announced voluntary Nasdaq delisting and SEC deregistration.</li>
</ul>
&nbsp;
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/04/31988185/wall-streets-most-accurate-analysts-say-buy-these-3-energy-stocks-delivering-high-divide"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks Delivering High-Dividend Yields</a>
&nbsp;
<h3>Commodities</h3>
In commodity news, oil traded down 2.5% to $76.80 while gold traded up 0.2% at $2,004.40.
Silver traded down 1.7% to $24.89 on Tuesday while copper fell 2.8% to $3.8450.
&nbsp;
<h3>Euro zone</h3>
European shares were mostly lower today. The eurozone&rsquo;s STOXX 600 fell 0.40%, London&rsquo;s FTSE 100 fell 0.27% while Spain&rsquo;s IBEX 35 Index fell 1.23% The German DAX rose 0.05%, French CAC 40 fell 0.56% and Italy&rsquo;s FTSE MIB Index fell 1.03%.
Producer prices in Spain dropped 1% year-over-year in March versus a revised 8% increase in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
Asian markets closed mixed on Tuesday, with Japan&rsquo;s Nikkei 225 gaining 0.09%, Hong Kong&rsquo;s Hang Seng Index falling 1.71% and China&rsquo;s Shanghai Composite Index declining 0.32%. India&rsquo;s S&amp;P BSE Sensex rose 0.3%.
Hong Kong&rsquo;s trade deficit widened to $40.6 billion in March from $37.3 billion in the year-ago month. Year-on-year, exports declined 1.5% to $367.2 billion.
&nbsp;
<h3>Economics</h3>
<ul>
<li>The S&amp;P CoreLogic Case-Shiller 20-city home price index rose 0.4% year-over-year in February, recording the smallest growth since 2012, and versus a 2.6% increase in January.</li>
<li>US house price index climbed by 0.5% from a month ago in February, the FHFA said.</li>
<li>Sales of new single-family houses rose 9.3% month-over-month to an annualised rate of 683,000 in March.</li>
<li>The Dallas Fed general business activity index for Texas&#39; service <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a> rose to -14.4 in April versus -18 in March.</li>
<li>The Manufacturing Activity Index in the Richmond area declined to -10 in April compared to previous month&rsquo;s reading of -5.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/04/31987309/procter-gamble-crocs-and-these-2-stocks-insiders-are-selling"> Procter &amp; Gamble, Crocs And These 2 Stocks Insiders Are Selling</a>
&nbsp;
<h3>COVID-19 Update</h3>
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 106,580,790 cases with around 1,159,310 deaths. India confirmed a total of at least 44,905,820 cases and 531,360 deaths, while France reported over 39,951,430 COVID-19 cases with 166,280 deaths. In total, there were at least 686,587,930 cases of COVID-19 worldwide with more than 6,860,230 deaths.

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

AGFY

HMST

SPPI

VIRI

VYNT

Dow Dips Over 300 Points; McDonald's Beats Q1 Expectations

Goldman Sachs maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Neutral and raises the price target from $12 to $13.4.

Goldman Sachs Maintains Neutral on United Breweries Co, Raises Price Target to $13.4

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>)</h3>
<ul>
<li>Beyond Meat Chief Brand Officer is leaving the company, the Wall Street Journal reported. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/BYND">52-week high of $68.06 </a>.</li>
<li>RSI Value: 70.03</li>
<li>BYND Price Action: Shares of Beyond Meat gained 11.3% to settle at $16.83 on Monday and lost 0.1% in after-hours trading.</li>
</ul>
<h2>Dole plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dole#NYSE">DOLE</a>)</h2>
<ul>
<li>Dole, during November, posted upbeat Q3 earnings. The company&rsquo;s <a href="https://www.benzinga.com/quote/DOLE"> stock has a 52-week high </a> of $15.78.</li>
<li>RSI Value: 71.73</li>
<li>DOLE Price Action: Shares of Dole gained 3.9% to close at $10.50 on Monday and added 1.1% in after-hours trading.</li>
</ul>
<h3>Coca-Cola FEMSA, S.A.B. de C.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kof#NYSE">KOF</a>)</h3>
<ul>
<li>B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $137 to $157. The company has a <a href="https://www.benzinga.com/quote/KOF"> 52-week high </a> of $75.17.</li>
<li>RSI Value: 71.31</li>
<li>KOF Price Action: Shares of Coca-Cola FEMSA rose 3.6% to close at $73.38 on Monday and added 0.4% in after-hours trading.</li>
</ul>
<h3>The Est&eacute;e Lauder Companies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/el#NYSE">EL</a>)</h3>
<ul>
<li>Morgan Stanley recently maintained Estee Lauder with an Overweight and raised the <a href="https://www.benzinga.com/quote/EL"> price target </a> from $271 to $281. The company&rsquo;s 52-week high is $324.70.</li>
<li>RSI Value: 72.36</li>
<li>EL Price Action: Shares of Est&eacute;e Lauder rose 2.6% to close at $274.49 on Monday.</li>
</ul>
<h3>Compa&ntilde;&iacute;a Cervecer&iacute;as Unidas S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccu#NYSE">CCU</a>)</h3>
<ul>
<li>The company&rsquo;s stock gained 17% over the past month. The company <a href="https://www.benzinga.com/quote/CCU"> has a 52-week high </a> of $17.21.</li>
<li>RSI Value: 77.63</li>
<li>CCU Price Action: Shares of Compa&ntilde;&iacute;a Cervecer&iacute;as Unidas rose 2.5% to settle at $15.07 on Monday and lost 3% in after-hours trading.</li>
</ul>
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/01/30524393/3-stocks-insiders-are-buying-coinbase-global-and-more"> 3 Stocks Insiders Are Buying: Coinbase Global And More </a>

Short Ideas

Pre-Market Outlook

Trading Ideas

DOLE

Top 5 Defensive Stocks That May Plunge

<ul>
<li>Credit Suisse raised Universal Health Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uhs#NYSE">UHS</a>) price target from $129 to $157. Credit Suisse analyst Jonathan Yong maintained an Outperform rating on the stock. Universal Health fell 2.7% to $126.15 in pre-market trading.</li>
<li>UBS raised Deere &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/de#NYSE">DE</a>) price <a href="https://www.benzinga.com/quote/DE/analyst-ratings"> target from $374 to $452. </a>. UBS analyst Steven Fisher maintained a Neutral rating on the stock. Deere shares slipped 0.1% to $437.46 in pre-market trading.</li>
<li>Credit Suisse cut the price target on Lufax Holding Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lu#NYSE">LU</a>) from $1.7 to $1.4. Credit Suisse analyst Frank Zheng downgraded the stock from Neutral to Underperform. Lufax shares fell 14.9% to $1.49 in pre-market trading.</li>
<li>Barclays cut Medtronic plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mdt#NYSE">MDT</a>) price target from $90 to $85. Barclays analyst Matt Miksic maintained an Equal-Weight rating on the stock. Medtronic shares gained 0.5% to $79.40 in pre-market trading.</li>
<li>JP Morgan raised Compa&ntilde;&iacute;a Cervecer&iacute;as Unidas S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccu#NYSE">CCU</a>) price target from $13 to $14. JP Morgan analyst Lucas Ferreira maintained a Neutral rating on the stock. Compa&ntilde;&iacute;a Cervecer&iacute;as Unidas shares rose 2% to close at $11.85 on Wednesday.</li>
<li>Mizuho cut Fidelity National Information Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) price target from $105 to $90. Mizuho analyst Dan Dolev maintained a Buy rating on the stock. Fidelity National Information shares fell 3% to $63.95 in pre-market trading.</li>
</ul>
<a href="https://www.benzinga.com/news/22/11/29856655/citi-turns-bullish-on-tesla-heres-a-look-at-other-price-target-changes-by-the-most-accurate-analysts">Check out this: Citi Turns Bullish On Tesla; Here&#39;s A Look At Other Price Target Changes By The Most Accurate Analysts </a>

Universal Health Services To Rally Around 25%? Here Are 5 Other Price Target Changes For Friday

JP Morgan analyst Lucas Ferreira maintains United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) with a Neutral and raises the price target from $13 to $14.

JP Morgan Maintains Neutral on United Breweries Co, Raises Price Target to $14

HSBC analyst Sorabh Daga downgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Buy to Hold and lowers the price target from $15 to $13.

HSBC Downgrades United Breweries Co to Hold, Lowers Price Target to $13

<h3>Upgrades</h3>
According to B of A Securities, the prior rating for Prothena Corp PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) was changed from Neutral to Buy. Prothena Corp earned $0.88 in the second quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Prothena Corp shows a 52-week-high of $49.77 and a 52-week-low of $21.06. Moreover, at the end of the last trading period, the closing price was at $30.93. 
According to Wolfe Research, the prior rating for Healthpeak Properties Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEAK#NYSE">PEAK</a>) was changed from Peer Perform to Outperform. For the second quarter, Healthpeak Properties had an EPS of $0.44, compared to year-ago quarter EPS of $0.40. The current stock performance of Healthpeak Properties shows a 52-week-high of $36.85 and a 52-week-low of $22.66. Moreover, at the end of the last trading period, the closing price was at $22.80. 
Piper Sandler upgraded the previous rating for SouthState Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NASDAQ">SSB</a>) from Neutral to Overweight. In the second quarter, SouthState showed an EPS of $1.62, compared to $1.87 from the year-ago quarter. The stock has a 52-week-high of $93.34 and a 52-week-low of $72.25. At the end of the last trading period, SouthState closed at $77.63. 
CL King upgraded the previous rating for Steven Madden Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOO#NASDAQ">SHOO</a>) from Neutral to Buy. Steven Madden earned $0.63 in the second quarter, compared to $0.48 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.84 and a 52-week-low of $26.36. Steven Madden closed at $26.69 at the end of the last trading period. 
For United Breweries Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>), JP Morgan upgraded the previous rating of Underweight to Neutral. For the second quarter, United Breweries Co had an EPS of $0.19, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $17.78 and a 52-week-low of $9.31. United Breweries Co closed at $9.60 at the end of the last trading period. 
Evercore ISI Group upgraded the previous rating for Illumina Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) from In-Line to Outperform. For the second quarter, Illumina had an EPS of $0.57, compared to year-ago quarter EPS of $1.87. The current stock performance of Illumina shows a 52-week-high of $428.00 and a 52-week-low of $173.45. Moreover, at the end of the last trading period, the closing price was at $186.84. 
For Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), Atlantic Equities upgraded the previous rating of Neutral to Overweight. Netflix earned $3.20 in the second quarter, compared to $2.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $609.99 and a 52-week-low of $162.71. Netflix closed at $224.36 at the end of the last trading period. 
Baird upgraded the previous rating for Biogen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) from Neutral to Outperform. For the second quarter, Biogen had an EPS of $5.25, compared to year-ago quarter EPS of $5.68. The current stock performance of Biogen shows a 52-week-high of $249.00 and a 52-week-low of $187.16. Moreover, at the end of the last trading period, the closing price was at $197.79. 
BMO Capital upgraded the previous rating for Biogen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) from Market Perform to Outperform. Biogen earned $5.25 in the second quarter, compared to $5.68 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of $249.00 and a 52-week-low of $187.16. Moreover, at the end of the last trading period, the closing price was at $197.79. 
Piper Sandler upgraded the previous rating for Truist Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) from Neutral to Overweight. Truist Financial earned $1.20 in the second quarter, compared to $1.55 in the year-ago quarter. At the moment, the stock has a 52-week-high of $68.95 and a 52-week-low of $42.56. Truist Financial closed at $43.04 at the end of the last trading period. 
For Biogen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>), Mizuho upgraded the previous rating of Neutral to Buy. For the second quarter, Biogen had an EPS of $5.25, compared to year-ago quarter EPS of $5.68. The stock has a 52-week-high of $249.00 and a 52-week-low of $187.16. At the end of the last trading period, Biogen closed at $197.79. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
<h3>Downgrades</h3>
B of A Securities downgraded the previous rating for Equitrans Midstream Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETRN#NYSE">ETRN</a>) from Neutral to Underperform. In the second quarter, Equitrans Midstream showed an EPS of $0.11, compared to $0.13 from the year-ago quarter. The current stock performance of Equitrans Midstream shows a 52-week-high of $11.22 and a 52-week-low of $5.87. Moreover, at the end of the last trading period, the closing price was at $7.81. 
According to DA Davidson, the prior rating for Lakeland Bancorp Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBAI#NASDAQ">LBAI</a>) was changed from Buy to Neutral. In the second quarter, Lakeland Bancorp showed an EPS of $0.44, compared to $0.53 from the year-ago quarter. The current stock performance of Lakeland Bancorp shows a 52-week-high of $20.69 and a 52-week-low of $13.91. Moreover, at the end of the last trading period, the closing price was at $16.37. 
For CSX Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), Susquehanna downgraded the previous rating of Positive to Neutral. In the second quarter, CSX showed an EPS of $0.50, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $38.63 and a 52-week-low of $26.90. CSX closed at $27.22 at the end of the last trading period. 
According to Susquehanna, the prior rating for Norfolk Southern Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) was changed from Positive to Neutral. In the second quarter, Norfolk Southern showed an EPS of $3.45, compared to $3.28 from the year-ago quarter. The stock has a 52-week-high of $298.99 and a 52-week-low of $211.66. At the end of the last trading period, Norfolk Southern closed at $213.84. 
According to Oppenheimer, the prior rating for Avient Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVNT#NYSE">AVNT</a>) was changed from Outperform to Perform. Avient earned $0.98 in the second quarter, compared to $0.87 in the year-ago quarter. At the moment, the stock has a 52-week-high of $58.60 and a 52-week-low of $30.81. Avient closed at $31.04 at the end of the last trading period. 
According to Janney Montgomery Scott, the prior rating for Lakeland Bancorp Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBAI#NASDAQ">LBAI</a>) was changed from Buy to Neutral. In the second quarter, Lakeland Bancorp showed an EPS of $0.44, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $20.69 and a 52-week-low of $13.91. At the end of the last trading period, Lakeland Bancorp closed at $16.37. 
Wells Fargo downgraded the previous rating for Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from Equal-Weight to Underweight. Lockheed Martin earned $6.32 in the second quarter, compared to $6.52 in the year-ago quarter. The current stock performance of Lockheed Martin shows a 52-week-high of $479.99 and a 52-week-low of $353.03. Moreover, at the end of the last trading period, the closing price was at $399.74. 
According to William Blair, the prior rating for PhaseBio Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAS#NASDAQ">PHAS</a>) was changed from Outperform to Market Perform. For the second quarter, PhaseBio Pharmaceuticals had an EPS of $0.34, compared to year-ago quarter EPS of $0.60. The current stock performance of PhaseBio Pharmaceuticals shows a 52-week-high of $2.70 and a 52-week-low of $0.50. Moreover, at the end of the last trading period, the closing price was at $0.76. 
Wells Fargo downgraded the previous rating for L3Harris Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) from Overweight to Equal-Weight. In the second quarter, L3Harris Technologies showed an EPS of $3.23, compared to $3.26 from the year-ago quarter. The stock has a 52-week-high of $279.71 and a 52-week-low of $206.04. At the end of the last trading period, L3Harris Technologies closed at $212.56. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
<h3>Initiations</h3>
Raymond James initiated coverage on Ivanhoe Electric Inc (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IE#AMEX">IE</a>) with an Outperform rating. The price target for Ivanhoe Electric is set to $12.00. For the second quarter, Ivanhoe Electric had an EPS of $0.85, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of $12.04 and a 52-week-low of $7.01. Ivanhoe Electric closed at $8.11 at the end of the last trading period. 
With a Buy rating, Maxim Group initiated coverage on BioRestorative Therapies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>). The price target seems to have been set at $6.00 for BioRestorative Therapies. For the second quarter, BioRestorative Therapies had an EPS of $1.28, compared to year-ago quarter EPS of $5.10. The current stock performance of BioRestorative Therapies shows a 52-week-high of $5.97 and a 52-week-low of $2.46. Moreover, at the end of the last trading period, the closing price was at $2.46. 
For Sabre Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>), Redburn Partners initiated coverage, by setting the current rating at Buy. For the second quarter, Sabre had an EPS of $0.25, compared to year-ago quarter EPS of $0.52. At the moment, the stock has a 52-week-high of $12.08 and a 52-week-low of $5.03. Sabre closed at $5.10 at the end of the last trading period. 
Northland Capital Markets initiated coverage on Sunrun Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) with an Outperform rating. The price target for Sunrun is set to $60.00. For the second quarter, Sunrun had an EPS of $0.06, compared to year-ago quarter EPS of $0.20. The current stock performance of Sunrun shows a 52-week-high of $39.13 and a 52-week-low of $16.80. Moreover, at the end of the last trading period, the closing price was at $30.24. 
For Haleon PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLN#NYSE">HLN</a>), Argus Research initiated coverage, by setting the current rating at Hold. NoneThe stock has a 52-week-high of $7.65 and a 52-week-low of $5.59. At the end of the last trading period, Haleon closed at $5.85. 
With an Overweight rating, Wells Fargo initiated coverage on Crescent Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>). The price target seems to have been set at $18.00 for Crescent Energy. The current stock performance of Crescent Energy shows a 52-week-high of $19.65 and a 52-week-low of $10.86. Moreover, at the end of the last trading period, the closing price was at $12.84. 
B. Riley Securities initiated coverage on Franklin BSP Realty Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) with a Buy rating. The price target for Franklin BSP Realty Trust is set to $16.00. For the second quarter, Franklin BSP Realty Trust had an EPS of $0.29, compared to year-ago quarter EPS of $0.57. The stock has a 52-week-high of $16.20 and a 52-week-low of $11.24. At the end of the last trading period, Franklin BSP Realty Trust closed at $11.34. 
Baird initiated coverage on CNH Industrial NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>) with an Outperform rating. The price target for CNH Industrial is set to $17.00. In the second quarter, CNH Industrial showed an EPS of $0.43, compared to $0.42 from the year-ago quarter. The stock has a 52-week-high of $17.13 and a 52-week-low of $10.60. At the end of the last trading period, CNH Industrial closed at $11.04. 
With a Buy rating, Stifel initiated coverage on Vizsla Silver Corp (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VZLA#AMEX">VZLA</a>). The price target seems to have been set at $3.50 for Vizsla Silver. At the moment, the stock has a 52-week-high of $2.39 and a 52-week-low of $0.91. Vizsla Silver closed at $1.08 at the end of the last trading period. 
With a Hold rating, Jefferies initiated coverage on Generac Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>). The price target seems to have been set at $190.00 for Generac Hldgs. For the second quarter, Generac Hldgs had an EPS of $2.99, compared to year-ago quarter EPS of $2.39. At the moment, the stock has a 52-week-high of $353.98 and a 52-week-low of $167.11. Generac Hldgs closed at $180.22 at the end of the last trading period. 
With an Outperform rating, Baird initiated coverage on AGCO Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>). The price target seems to have been set at $156.00 for AGCO. In the second quarter, AGCO showed an EPS of $2.38, compared to $2.88 from the year-ago quarter. At the moment, the stock has a 52-week-high of $150.28 and a 52-week-low of $88.55. AGCO closed at $94.40 at the end of the last trading period. 
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

AGCO

AVNT

BIIB

BRTX

CNHI

CRGY

ETRN

FBRT

GNRC

ILMN

LBAI

NFLX

PEAK

PHAS

PRTA

SABR

SHOO

VZLA

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022

JP Morgan analyst Lucas Ferreira upgrades United Breweries Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCU#NYSE">CCU</a>) from Underweight to Neutral and announces $13 price target.

JP Morgan Upgrades United Breweries Co to Neutral, Announces $13 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
United Breweries Co (NYSE:<a href="https://investorplace.com/stock-quotes/ccu-stock-quote/">CCU</a>) just reported results for the second quarter of 2024.<ul><li>United Breweries Co reported earnings per share of 7 cents. This was below the analyst estimate for EPS of 9 cents.</li><li>The company reported revenue of $561.89 million.</li><li>This was 15.95% worse than the analyst estimate for revenue of $668.53 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ccu-stock-earnings-united-breweries-co-for-q2-of-2024/">CCU Stock Earnings: United Breweries Co Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CCU Stock Earnings: United Breweries Co Misses EPS, Misses Revenue for Q2 2024

Compañía Cervecerías Unidas downgraded at Goldman Sachs

Compania Cervecerias Unidas SA (CCU) has released an update. Compania Cervecerias Unidas S.A., also known as United Breweries Company, Inc., has re...

CCU Manages Cybersecurity Breach, Assesses Impact

Compania Cervecerias Unidas SA (CCU) has released an update. Compañía Cervecerías Unidas S.A. has reported that the recent cybersecurity incident h...

CCU Confirms Cybersecurity Incident Contained

Compania Cervecerias Unidas SA (CCU) has released an update. Compañía Cervecerías Unidas S.A. (CCU) has expanded its presence in Paraguay by acquir...

CCU Expands in Paraguay with Strategic Acquisition

Compania Cervecerias Unidas SA (CCU) has released an update. Compania Cervecerias Unidas SA (CCU) reported a significant 211.1% increase in net inc...

CCU Reports Strong Net Income Growth Amid Challenges

Compania Cervecerias Unidas SA (CCU) has released an update. Compania Cervecerias Unidas SA, a prominent beverage company operating in Latin Americ...

Compania Cervecerias Unidas Announces Interim Dividend

Compania Cervecerias Unidas S.A. reports Q3 results

Compania Cervecerias Unidas SA (CCU) has released an update. Compañía Cervecerías Unidas S.A., a major player in the brewing industry, reported a r...

Comments

United Breweries Co

Noticias

Últimas noticias sobre United Breweries Co (NYSE:CCU) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL